CYBC1通过ROS和NF-κB途径驱动质母细胞瘤的进展
Hyeon Ji Kim1, Tae-Jun Kim1, Jin-Hwa Cho1
1Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu, Korea.
Cancer research and treatment
|December 27, 2024
概括
细胞染色体b-245 chaperone 1 (CYBC1) 通过增加活性氧物种 (ROS) 和激活关键信号通路来促进质母细胞瘤 (GBM) 的生长. 准CYBC1可能为GBM患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑瘤.
- 了解GBM进展的分子驱动因素对于开发有效治疗方法至关重要.
研究的目的:
- 调查细胞染色体b-245陪伴1 (CYBC1) 在质母细胞瘤 (GBM) 进展中的作用.
- 阐明CYBC1在活性氧物种 (ROS) 生产和相关信号通路中的参与.
- 确定CYBC1作为GBM的潜在治疗标和预后标志物.
主要方法:
- 对CYBC1表达和患者生存相关性的公开可用的GBM数据集的分析.
- 使用CRISPR/Cas9对GBM细胞系进行基因操纵,以耗尽CYBC1.1.
- 评估CYBC1缺陷对细胞增殖,迁移,入侵和细胞周期的影响.
- 探索CYBC1对NOXA1表达和NF-κB信号通路的影响.
主要成果:
- 在GBM组织中,CYBC1的表达显著升高,并与患者的存活率较低有关.
- CYBC1的枯竭减少了GBM细胞的活力,迁移和入侵.
- CYBC1积极调节NOXA1,增强ROS的产生和激活ERK·AKT/NF-κB通路.
- 抑制CYBC1降低了ROS,降低了NF-κB酸化,并降低了表皮-介质细胞过渡标志物的调节.
结论:
- CYBC1通过NOXA1介导的ROS产生和ERK·AKT/NF-κB通路激活促进GBM的进展.
- CYBC1代表了质母细胞瘤的潜在治疗标和预后生物标志物.
- 对CYBC1的机制和治疗潜力的进一步研究是有必要的.
相关概念视频
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Electron Transport Chain: Complex I and II
9.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.5K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K


